Quantum BioPharma Ltd. Proceeds From Issue Of Bonds Notes And Debentures
Quantum BioPharma Ltd. (QNTM) reported Proceeds From Issue Of Bonds Notes And Debentures of $3.24 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:ProceedsFromIssueOfBondsNotesAndDebentures · last filed 2026-03-26
- Quantum BioPharma Ltd. proceeds from issue of bonds notes and debentures for the quarter ending 2025-12-31 was $42.49K, a 93.95% decline year-over-year.
- Quantum BioPharma Ltd. proceeds from issue of bonds notes and debentures for the quarter ending 2025-09-30 was $237.28K.
- Quantum BioPharma Ltd. proceeds from issue of bonds notes and debentures for the quarter ending 2025-06-30 was $296.00K.
- Quantum BioPharma Ltd. proceeds from issue of bonds notes and debentures for the quarter ending 2025-03-31 was $2.67M.
| Period end | Proceeds From Issue Of Bonds Notes And Debentures 3 month | Proceeds From Issue Of Bonds Notes And Debentures 6 month | Proceeds From Issue Of Bonds Notes And Debentures 9 month | Proceeds From Issue Of Bonds Notes And Debentures 12 month |
|---|---|---|---|---|
| 2025-12-31 | $42.49K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | $279.76K derived: sum of 2 quarters · filed 2026-03-26 | $575.76K derived: sum of 3 quarters · filed 2026-03-26 | $3.24M 20-F · filed 2026-03-26 |
| 2025-09-30 | $237.28K derived: 6-K 9 month − 6-K 6 month · filed 2025-11-06 | $533.27K derived: sum of 2 quarters · filed 2025-11-06 | $3.20M 6-K · filed 2025-11-06 | $3.90M derived: sum of 4 quarters · filed 2026-03-26 |
| 2025-06-30 | $296.00K derived: 6-K 6 month − 6-K/A 3 month · filed 2025-08-07 | $2.96M 6-K · filed 2025-08-07 | $3.67M derived: sum of 3 quarters · filed 2026-03-26 | $3.67M derived: sum of 4 quarters · filed 2026-03-26 |
| 2025-03-31 | $2.67M 6-K/A · filed 2025-06-16 | $3.37M derived: sum of 2 quarters · filed 2026-03-26 | $3.37M derived: sum of 3 quarters · filed 2026-03-26 | $3.37M derived: sum of 4 quarters · filed 2026-03-26 |
| 2024-12-31 | $702.70K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | $702.70K derived: sum of 2 quarters · filed 2026-03-26 | $702.70K derived: sum of 3 quarters · filed 2026-03-26 | $702.70K 20-F · filed 2026-03-26 |
| 2024-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 6-K · filed 2025-11-06 | |
| 2024-06-30 | $0.00 derived: 6-K 6 month − 6-K/A 3 month · filed 2025-08-07 | $0.00 6-K · filed 2025-08-07 | ||
| 2024-03-31 | $0.00 6-K/A · filed 2025-06-16 | |||
| 2023-12-31 | $0.00 20-F · filed 2026-03-26 |